Works matching IS 01615505 AND DT 2021 AND VI 62 AND IP 2

Results: 22

Advancing Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 20N

By:

Wahl, Richard L.

Publication type:

Article

FDA Announces Priority Review of 18 F-DCFPyL NDA.

Published in:: Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 21N
Publication type:: Article

68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 149, doi. 10.2967/jnumed.120.260455

By:

Carlucci, Giuseppe;
Ippisch, Robin;
Slavik, Roger;
Mishoe, Ashley;
Blecha, Joseph;
Shaojun Zhu

Publication type:

Article

2020 SNMMI Highlights Lecture: Neuroscience.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 12N

By:

Price, Julie

Publication type:

Article

FDA Approves First PSMA-Targeted PET Drug.

Published in:: Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 11N
Publication type:: Article

Detection of Early Progression with 18F‐DCFPyL PET/CT in Men with Metastatic Castration‐Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.259226

By:

Markowski, Mark C.;
Isaacsson Velho, Pedro;
Eisenberger, Mario A.;
Pomper, Martin G.;
Pienta, Kenneth J.;
Gorin, Michael A.;
Antonarakis, Emmanuel S.;
Denmeade, Samuel R.;
Rowe, Steven P.

Publication type:

Article

LETTER TO THE EDITOR: ON POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.261874

By:

Dadachova, Ekaterina

Publication type:

Article

The Evolution of PET/MR is Hindered by our Field’s Reluctance to Provide Critical Evaluation.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.260950

By:

Kesner, Adam L.

Publication type:

Article

Standardized Uptake Values are Adequate Measures of Lesional 18F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.260232

By:

Bodar, Yves J. L.;
Koene, Berend P. F.;
Jansen, Bernard H. E.;
Cysouw, Matthijs C. F.;
Meijer, Dennie;
Hendrikse, N. Harry;
Vis, André N.;
Boellaard, Ronald;
Oprea‐Lager, Daniela E.

Publication type:

Article

Optical navigation of a DROP-IN gamma probe as a means to strengthen the connection between robot-assisted and radioguided surgery.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.259796

By:

Azargoshasb, Samaneh;
Houwing, Krijn H. M.;
Roos, Paul R.;
van Leeuwen, Sven I.;
Boonekamp, Michael;
Mazzone, Elio;
Bauwens, Kevin;
Dell’Oglio, Paolo;
van Leeuwen, F. W. B.;
van Oosterom, Matthias N.

Publication type:

Article

RADIOGUIDED SURGERY.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.261888

By:

Mariani, Giuliano;
Valdés Olmos, Renato A.;
Vidal-Sicart, Sergi;
Strauss, H. William

Publication type:

Article

The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.257931

By:

Armstrong, Wesley R.;
Gafita, Andrei;
Shaojun Zhu;
Thin, Pan;
Nguyen, Kathleen;
Alano, Rejah;
Lira, Stephanie;
Booker, Kiara;
Gardner, Linda;
Grogan, Tristan;
Elashoff, David;
Allen-Auerbach, Martin;
Dahlbom, Magnus;
Czernin, Johannes;
Calais, Jeremie

Publication type:

Article

[68Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.257915

By:

Hirmas, Nader;
Leyh, Catherine;
Sraieb, Miriam;
Barbato, Francesco;
Schaarschmidt, Benedikt M.;
Umutlu, Lale;
Nader, Michael;
Wedemeyer, Heiner;
Ferdinandus, Justin;
Rischpler, Christoph;
Herrmann, Ken;
Fragoso Costa, Pedro;
Lange, Christian M.;
Weber, Manuel;
Fendler, Wolfgang P.

Publication type:

Article

Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta‐analysis.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.257303

By:

Whitman, Julia;
Allen, Isabel E.;
Bergsland, Emily K.;
Suh, Insoo;
Hope, Thomas A.

Publication type:

Article

QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.256602

By:

Wibmer, Andreas G.;
Morris, Michael;
Gonen, Mithat;
Zheng, Junting;
Hricak, Hedvig;
Larson, Steven;
Scher, Howard I.;
Alberto Vargas, Hebert

Publication type:

Article

HYPERMETABOLISM ON PEDIATRIC POSITRON EMISSION TOMOGRAPHY SCANS OF BRAIN GLUCOSE METABOLISM: What does it signify?

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.256081

By:

Chugani, Harry T.

Publication type:

Article

Lymph node staging with a combined protocol of 18F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO I/II cervical carcinoma. .

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.255919

By:

Weissinger, Matthias;
Taran, Florin-Andrei;
Gatidis, Sergios;
Kommoss, Stefan;
Nikolaou, Konstantin;
Sahbai, Samine;
la Fougère, Christian;
Brucker, Sara Yvonne;
Dittmann, Helmut

Publication type:

Article

Evaluation of safety and dosimetry of 177Lu-DOTA-ZOL for therapy of bone metastases.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.255851

By:

Fernández, René;
Eppard, Elisabeth;
Lehnert, Wencke;
Jiménez-Franco, Luis David;
Soza-Ried, Cristian;
Ceballos, Matías;
Ribbeck, Jessica;
Kluge, Andreas;
Rösch, Frank;
Meckel, Marian;
Zhernosekov, Konstantin;
Kramer, Vasko;
Amaral, Horacio

Publication type:

Article

Identification of a PET Radiotracer for Imaging of the Folate Receptoralpha – A Potential Tool to Select Patients for Targeted Tumor Therapy.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.255760

By:

Guzik, Patrycja;
Hsin-Yu Fang;
Deberle, Luisa M.;
Benešová, Martina;
Cohrs, Susan;
Boss, Silvan D.;
Ametamey, Simon M.;
Schibli, Roger;
Müller, Cristina

Publication type:

Article

A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.253146

By:

Gan, Hui K.;
Burge, Matthew;
Solomon, Benjamin;
Lee, Sze Ting;
Holen, Kyle D.;
Yumin Zhang;
Ciprotti, Marika;
Lee, F. T.;
Munasinghe, Wijith;
Fischer, JuDee;
Ansell, Peter;
Fox, Gerard;
Hao Xiong;
Reilly, Edward B.;
Humerickhouse, Rod;
Scott, Andrew M.

Publication type:

Article

Simulation of low dose protocols for myocardial perfusion 82Rubidium imaging. .

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.252429

By:

Lassen, Martin Lyngby;
Otaki, Yuka;
Kavanagh, Paul;
Miller, Robert J. H.;
Berman, Daniel S.;
Slomka, Piotr J.

Publication type:

Article

Imaging calreticulin for early detection of immunogenic cell death during anticancer treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.245290

By:

Dong-Yeon Kim;
Ayoung Pyo;
Misun Yun;
Thangam, Ramar;
Sung-Hwan You;
Ying Zhang;
Ye-rim Jung;
Dinh-Huy Nguyen;
Venu, Akhil;
Hyeon Sik Kim;
Mee Sun Yoon;
Yeongjin Hong;
Jung-Joon Min

Publication type:

Article

Works matching IS 01615505 AND DT 2021 AND VI 62 AND IP 2

Advancing Radiopharmaceutical Therapy.

FDA Announces Priority Review of <sup>1</sup>8 F-DCFPyL NDA.

<sup>68</sup>Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.

2020 SNMMI Highlights Lecture: Neuroscience.

FDA Approves First PSMA-Targeted PET Drug.

Detection of Early Progression with <sup>18</sup>F‐DCFPyL PET/CT in Men with Metastatic Castration‐Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.

LETTER TO THE EDITOR: ON POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19.

The Evolution of PET/MR is Hindered by our Field’s Reluctance to Provide Critical Evaluation.

Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.

Optical navigation of a DROP-IN gamma probe as a means to strengthen the connection between robot-assisted and radioguided surgery.

RADIOGUIDED SURGERY.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

[<sup>68</sup>Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma.

Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta‐analysis.

QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY.

HYPERMETABOLISM ON PEDIATRIC POSITRON EMISSION TOMOGRAPHY SCANS OF BRAIN GLUCOSE METABOLISM: What does it signify?

Lymph node staging with a combined protocol of <sup>18</sup>F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO I/II cervical carcinoma. .

Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.

Identification of a PET Radiotracer for Imaging of the Folate Receptoralpha – A Potential Tool to Select Patients for Targeted Tumor Therapy.

A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.

Simulation of low dose protocols for myocardial perfusion <sup>82</sup>Rubidium imaging. .

Imaging calreticulin for early detection of immunogenic cell death during anticancer treatment.